Trytosaveabit commented on a stock · Jun 4 15:35

News

$Cellectis(CLLS.US)$ Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia
5 MINUTES AGO, 4:30 PM EDT
VIA GLOBENEWSWIRE

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

1498 Views

Comment

Trytosaveabit

2572Followers

28Following

34KVisitors